Aranda Pharma Ltd is a preclinical stage pharmaceutical company with proprietary R&D programs in dermatology and neurology. ADA-308 small molecules are potent topically applied androgen receptor antagonists targeting the underserved androgenetic alopecia (AGA) market while offering opportunity for acne as a second indication. ADA-409 small molecules are ferroptosis inhibitors with potential as disease modifying therapies for brain diseases.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Microkatu 1, Kuopio,finland,70210,finland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.arandapharma.com
- HQ
- Kuopio, Finland
Aranda Pharma Ltd Questions
Aranda Pharma Ltd's website is http://www.arandapharma.com
Aranda Pharma Ltd's LinkedIn profile is https://fi.linkedin.com/company/aranda-pharma-ltd
Aranda Pharma Ltd has
5 employees.
View email and phone details for 5
employees at Aranda Pharma Ltd.
Aranda Pharma Ltd's industry is
Biotechnology Research
Aranda Pharma Ltd's top competitors are
Admescope,
Rappta Therapeutics,
Tenboron Oy,
Tilt Biotherapeutics Ltd,
Galena Pharma Oy,
Capsamedix,
Herantis Pharma Plc.,
Aluke Oy,
Leadwin Oy,
Aboutmeds Oy.
Aranda Pharma Ltd's categories are Biotechnology Research
Aranda Pharma Ltd's founding year is 2015
